BMRN

#861
BioMarin Pharmaceuticals Inc
55.47 USD
+1.08%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
55.47
55.47
Rango anual
50.76
66.28
Cambio diario
+1.08%
Variación mensual
-2.12%
Variación en los últimos 6 meses
+5.98%
Cambio anual
-6.96%
Cierres anteriores
54.88
Abrir
55.47
Bid
Ask
Mínimo
55.47
High
55.47
Volumen
144
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 10.67 B
  • Employee 3 221
  • Founded N/A
  • CEO Alexander Hardy
  • Website www.biomarin.com
  • Headquarter Delaware, United States
  • FIGI BBG000CZWZ05
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
33.02
Relación precio/flujo de caja
3.64

BioMarin Pharmaceutical Inc

BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies. BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria. Over the years, BioMarin has been criticised for drug pricing and for specific instances of denying access to drugs in clinical trials.

Noticias